The product listed as 3D Systems Fused Deposition Modeling Material ABSM30i is an amorphous acrylonitrile-butadiene-styrene terpolymer supplied in sealed filament canisters for material-extrusion additive manufacturing using a heated chamber and removable support toolpaths. The model designation extends the ABS-M30 platform; the “i” suffix denotes a biocompatibility-validated feedstock and finished-print documentation package rather than a color designation or flame rating. The stock form is an opaque ivory filament wound on a keyed canister. Published mechanical data for the ivory medical-grade formulation include a Type I tensile strength of 31 MPa under ASTM D638-14, a flexural strength of 55 MPa under ASTM D790-17, a notched Izod impact of 106 J/m under ASTM D256-10, and a heat deflection temperature of 82 °C at 1.82 MPa under ASTM D648-18. The density is 1.04 g/cm³ under ASTM D792-20. Surface resistivity is in the insulative range above 10¹³ Ω per ASTM D257-14, so the material is not appropriate for static-dissipative electronics assembly without secondary treatment. The intended use envelope is non-implantable medical fixtures, surgical templates, drilling guides, and anatomical models requiring short-term skin or tissue contact documentation. Biocompatibility evidence is limited to cytotoxicity and irritation/sensitization testing under ISO 10993-5:2009 and ISO 10993-10:2013; these test results do not establish sterilization tolerance, mucosal contact duration, or implantable status. Compared with general-purpose ABS-M30, the biocompatibility-validated product adds raw-material lot traceability, controlled handling records, and documented test results, but its mechanical values are marginally lower than unmodified ABS-M30 in some orientations because the formulation is constrained to maintain biological test performance.

What Mechanical, Thermal, and Electrical Data Support the Selection of ABSM30i?

The data in the following table are representative as-printed values for XZ orientation specimens conditioned at 23 °C and 50% RH before testing. Fused deposition modeling is anisotropic; interlayer interfaces limit load transfer in the ZX orientation, so ZX tensile and flexural results may be lower than XZ values by 10–30% depending on layer height and build-chamber uniformity. The table does not provide design allowables. For structural components, the design organization should generate a minimum 5-specimen data set on the target FDM platform at the intended layer thickness and orientation.

On production FDM systems with a heated build chamber and dual extrusion heads, ABSM30i is typically processed at slice heights of 0.127 mm, 0.178 mm, 0.254 mm, or 0.330 mm. The choice is not cosmetic. A change from 0.127 mm to 0.330 mm reduces build time by roughly 60% but may lower ZX tensile values and surface resolution. Thin walls below 1.0 mm printed with soluble support are less prone to edge chipping than breakaway support; however, soluble support requires complete dissolution before the part enters a medical workflow. Residual support material packed into narrow drill-sleeve channels has been observed in surgical guide qualification as a source of cleaning failure because the entrapped polymer remains contaminated after routine washing. An agitated bath at 40–60 °C followed by filtered-water rinse and forced-air drying at 40 °C until mass stabilizes is standard practice. A heated chamber is mandatory. When the chamber setpoint falls below 80 °C, the first printed layers exhibit curl-induced delamination and interlayer separation; a setpoint of 90–100 °C and an extrusion tip temperature of 295–315 °C are representative starting conditions for standard dual-extrusion heads. Machine thermistor offsets vary across generations, so verifying these temperatures by infrared pyrometer or tower calibration is necessary before process qualification.

Feedstock Moisture and Build-Chamber Thresholds

ABSM30i is hygroscopic because the acrylonitrile repeat unit provides polar adsorption sites. Open canister exposure at relative humidity above 60% for 24 h can raise feedstock moisture to levels that produce melt splay, microvoid formation, and a measurable reduction in ZX tensile strength. If the canister has been left unsealed, a pre-drying cycle of 80 °C for 4 h in a dry-air oven with a dew point below -30 °C is required before printing. Drying above 90 °C is not recommended because the filament can soften and adhere to itself on the spool, causing feed failures. Raising extrusion temperature without drying does not correct water-related defects; it accelerates oxidative yellowing and can increase low-molecular-weight outgassing. The build chamber should be profiled across the actual build envelope. Edge-to-center temperature gradients greater than ±5 °C produce differential shrinkage in parts longer than 150 mm, which can lift the part from the build sheet or break vacuum during long deposition runs. Canister seals and desiccant packs are part of the material traceability chain; once opened, the canister should be closed immediately after the filament path is loaded, and a new desiccant pack should be inserted for extended storage.

Regulatory documentation for ABSM30i is not a device approval. The material has completed a defined battery of biological tests, but the finished device manufacturer remains responsible for evaluation under ISO 10993-1:2018, including chemical characterization and toxicological risk assessment. A certificate of conformance may be supplied for each production lot, but it does not cover contaminants introduced by the build chamber, support residue, sterilization residuals, or secondary finishing. If the printed part is coated, painted, solvent-polished, or machined after FDM, the original biocompatibility evidence no longer describes the final patient-contact surface, and the added process must be validated.

When the Part Moves Into a Sterile Workflow or Chemical Environment

ABSM30i has a heat deflection temperature of 82 °C at 1.82 MPa, and therefore steam autoclave cycles at 121 °C or 134 °C are generally outside the material’s useful service envelope; autoclaving produces dimensional distortion, irreversible creep in press-fit features, and surface whitening. Ethylene oxide sterilization is the most commonly compatible terminal method for low-temperature ABS medical parts, but the cycle must be validated under ISO 11135:2014. Aeration following EtO exposure is critical because styrenic matrices retain residual gas in internal porosity; insufficient aeration can leave residual EtO above the limits established in ISO 10993-7:2008. Gamma irradiation at typical terminal doses of 25 kGy may be feasible for single-use non-load-bearing fixtures but should be anticipated to reduce molecular weight and notched impact; published data for this specific configuration is limited, and dose mapping on representative geometry is required before release. Electron-beam sterilization can be used if dose rate is controlled, but the same oxidative degradation caveat applies. Chemical disinfectants should be restricted to those tested on the final printed surface because ketone, ester, and aromatic hydrocarbon solvents attack ABS. Repeated application of alcohol-based disinfectants can induce environmental stress cracking in thin flexures and snap features; this effect is intensified when the printed surface contains unannealed residual stress. The user should also verify compliance with RoHS 2011/65/EU and REACH 1907/2006 for the specific colorant and lubricant package at the article level.

Differences From ABS-M30, ABS-ESD7, and PC-ISO

The selection between ABSM30i and other FDM thermoplastics is controlled by three factors: biocompatibility documentation, thermal ceiling, and electrostatic behavior. The following table compares these attributes across common material options. Values are representative and do not replace application-specific qualification.

The choice between ABSM30i and PC-ISO often turns on sterilization and thermal exposure. PC-ISO is better suited to applications requiring repeated steam autoclave exposure because its HDT at 1.82 MPa is approximately 127 °C, but its deposition requires significantly higher chamber and tip temperatures, which increases energy use and warpage risk in large flat parts. ABS-ESD7 resolves electrostatic discharge concerns in electronics tooling but is not documented for medical contact and is not a drop-in substitute for surgical templates requiring biological evaluation. ABS-M30 may exhibit marginally higher tensile values than ABSM30i, but it lacks the raw-material traceability and biological test documentation necessary for short-term skin-contact medical fixtures. These differences are not additive: a part cannot be made biocompatible by simply adding a static-dissipative coating or a higher-temperature support material after deposition. The material selection must be locked before toolpath generation because the build-chamber settings, support material, and drying protocol differ among grades.